Like any other organ, the pancreas can develop tumours. However, not all tumours are cancerous, and pancreatic cancer has an aggressive nature and late diagnosis. Pancreatic cancer may be less ...
LM-302 is currently in phase 3 clinical trial for 3L and above gastric cancer in China. Pancreatic cancer has no approved immunotherapy, and the only approved treatment is a chemotherapy cocktail ...
The two companies have been conducting combination therapy study of the immuno-oncology drug GI-102 and ADC LM-302 targeting Claudin18.2 and recently observed excellent anticancer activity in a ...